Otsuka Clinical Trials
-
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autisti
-
Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug
-
Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
-
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic Peopl
-
A Study to Test the Effects of Itraconazole and Carbamazepine on OPC-167832 in Healthy Men and Women
-
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
-
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With
-
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PB
-
Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Ad
-
Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
-
A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term M
-
IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myelom
-
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
-
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).
-
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
Trials by company
PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan